Work

Real-world experience with atezolizumab plus bevacizumab (A+/-B) in Hispanic patients with advanced hepatocellular carcinoma (HCC) at a Hispanic-majority cancer center.

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.4_suppl.549

Authors: Jay Parekh, Neil Newman, Luisa Marie Arellano, Brittany Altermatt, Mary Salazar, Shannon Edwards, Lakshmi Balasubramanian, James Denno, Lorena Fuentes, LuZhe Sun, Sukeshi Patel Arora

Institutions: The University of Texas at San Antonio Health Science Center, Mays Cancer Center at UT Health San Antonio, The University of Texas Southwestern Medical Center

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4406869765

Cites:

Cited by:

Related to: 10